Clinical Trials

2,000 enrolled

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

29 enrolled

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

39 enrolled

Breast Neoplasms

NCT05659563 2026-03-19

EMPRESS

92 enrolled 14 charts

Breast Neoplasms

NCT00893061 2026-03-17

MNEMOSYNE

44 enrolled

Breast Neoplasms

NCT06982313 2026-03-11

Babytam long

Completed

1,545 enrolled

BreastOther neoplasm

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Precancerous Conditions

NCT00003042 2026-02-20

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

41 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT05101564 2026-02-12

Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer

19 enrolled 10 charts

Breast Neoplasms

NCT02668666 2026-01-20

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

49 enrolled 14 charts

Breast Neoplasms

NCT07145827 2025-09-12

Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen

Phase NA Completed

60 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Hyperplasia, Endometrial Neoplasms

NCT04300790 2025-07-29

METALLICA

69 enrolled

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT03554044 2025-05-21

T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

Phase 1 Completed

20 enrolled

Breast Neoplasms

NCT02040857 2025-04-29

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

162 enrolled 12 charts

Breast Neoplasms

NCT03219476 2025-04-29

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

37 enrolled 10 charts

Breast Neoplasms

NCT02206984 2025-03-11

Endocrine Response in Women With Invasive Lobular Breast Cancer

201 enrolled

Breast Neoplasms

NCT03346200 2025-03-07

KARISMA2

1,440 enrolled 14 charts

Breast Neoplasms, Risk Reduction Behavior

NCT03691493 2025-02-17

ASPIRE

36 enrolled 17 charts

Breast Neoplasms

NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Completed

88 enrolled

Breast Neoplasms, Depression, Hot Flashes

NCT00949598 2025-02-13

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

177 enrolled

Breast Neoplasms

NCT04079517 2025-02-06

Karisma-1

Phase 1/2 Completed

42 enrolled 6 charts

Breast Neoplasms

NCT02993159 2024-12-18

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

100 enrolled 15 charts

Carcinoma, Intraductal, Noninfiltrating

NCT00002644 2024-12-11

IBIS-1

7,154 enrolled

Breast Neoplasms

NCT03355157 2024-10-01

PADMA

130 enrolled

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Patient Acceptance of Health Care

NCT02913430 2024-09-23

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

7 enrolled 13 charts

Breast Neoplasms

NCT00072462 2024-09-19

IBIS-II DCIS

2,980 enrolled 14 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04129216 2024-05-07

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

30 enrolled 10 charts

Breast Neoplasms

NCT03870399 2024-05-06

HORMONET

23 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT00499083 2023-09-29

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

17 enrolled 5 charts

Breast Neoplasms

NCT01298713 2023-09-06

Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

111 enrolled

Breast Neoplasms

NCT02584465 2023-09-06

REGOVAR

68 enrolled

Gynecologic

Ovarian Neoplasms

NCT00866554 2023-06-02

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

60 enrolled

Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT02285179 2022-10-12

Poseidon

Phase 1/2 Completed

189 enrolled

Breast Neoplasms

NCT03948568 2022-09-30

REaCT-RETT

262 enrolled

Breast Neoplasms

NCT02384239 2022-03-16

A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer

70 enrolled 16 charts

Breast Neoplasms

NCT01831076 2022-03-03

Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

36 enrolled 6 charts

Breast Neoplasms

NCT00710970 2022-01-24

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

28 enrolled 8 charts

Genitourinary

Urinary Bladder Neoplasms

NCT02586675 2022-01-21

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

Phase 1 Completed

7 enrolled 8 charts

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT02988986 2021-09-22

ANETT

28 enrolled 9 charts

Breast Neoplasms

NCT01220076 2021-03-12

TAM

140 enrolled

Non Metastatic Breast Cancer

NCT02197897 2021-01-13

BCTamoxifen

15 enrolled 5 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00290745 2020-12-04

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Phase 1/2 Completed

79 enrolled 15 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01192308 2020-12-01

KINETAM

Phase 1 Completed

42 enrolled

Breast Neoplasms

NCT01950182 2020-07-15

SYSUCC-002

392 enrolled

Breast Neoplasms

NCT02866955 2020-03-09

EFESE

100 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02291913 2020-02-17

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

48 enrolled 13 charts

Breast Neoplasms

NCT00240071 2019-10-30

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

30 enrolled 7 charts

Breast Neoplasms

NCT02344940 2019-09-24

TTOS

104 enrolled

Breast Neoplasms

NCT03715413 2019-03-07

Analgesic Efficacy of Pulsed Radiofrequency in Non-cyclic Mastalgia

64 enrolled

Fibroadenoma

NCT01638247 2018-09-19

MALE

56 enrolled